Pharma companies optimistic on Indo-US deal corridor: Report

摘要

Despite the increasing protectionist tendencies in the US, the domestic pharma sector, which saw 51 deals worth $4.6-bn in 2016, is cautiously optimistic about inbound deals from the American shores this year, says a report.